Quikhale Sf 250 Hfa Based Inhaler

(0 customer reviews)

Quikhale Sf 250 Hfa

Clear

In Stock

1 / 3

Quikhale Sf 250 Hfa Based Inhaler – image 1

Quikhale Sf 250 Hfa Based Inhaler

In Stock

Secure
Checkout

Free
Shipping

30-Day
Returns

Quality
Guaranteed

Quantity

Quikhale Sf 250 Hfa

Clear

Safe Payment

All major cards & wallets accepted

Premium Quality

Tested to highest standards

24/7 Support

We're here whenever you need us

Money-Back Guarantee

30-day no questions asked

What Is Quikhale SF 250 HFA Based Inhaler?

Quikhale SF 250 HFA Based Inhaler is a fixed-dose combination pressurised metered dose inhaler (pMDI) manufactured by Intas Pharmaceuticals Ltd — a leading Indian pharmaceutical company with a strong global presence. The name "SF" stands for Salmeterol and Fluticasone, the two active ingredients it delivers: Salmeterol Xinafoate 50mcg, a long-acting bronchodilator, and Fluticasone Propionate 250mcg, a potent inhaled corticosteroid. The HFA (hydrofluoroalkane) propellant makes this inhaler completely CFC-free, delivering a fine aerosol mist deep into the airways with each actuation. As a daily maintenance inhaler, Quikhale SF is not a rescue inhaler for sudden attacks — it must be used regularly for ongoing control. Explore the full inhalers range at Ed Care Store.

What Is Quikhale SF 250 Used For?

Asthma Maintenance

Quikhale SF 250 is prescribed for adults and adolescents (12+) whose asthma remains uncontrolled on an inhaled corticosteroid alone. It reduces daytime and nocturnal symptoms, prevents exercise-induced bronchospasm, and lowers exacerbation risk. Initial improvement may appear within a few days, but maximum benefit typically builds over several weeks of consistent daily use.

COPD Management

For adults with moderate to severe COPD, Quikhale SF 250 reduces breathlessness, improves exercise tolerance, and lowers exacerbation frequency. Stopping it prematurely — even when feeling well — can rapidly worsen respiratory control. For helpful respiratory health reading, visit the Ed Care Store Blog.

How Does Quikhale SF 250 Inhaler Work?

Fluticasone Propionate — Anti-Inflammatory Control

Fluticasone works intracellularly — entering airway epithelial cells and suppressing pro-inflammatory genes responsible for histamines, leukotrienes, and cytokines. This reduces the airway swelling, mucus overproduction, and hypersensitivity to triggers that characterise asthma and COPD. Delivered via inhalation, it reaches the airway tissues directly with minimal systemic absorption — far safer for long-term use than oral corticosteroids.

Salmeterol Xinafoate — Sustained Bronchodilation

Salmeterol is a selective long-acting beta-2 agonist (LABA) that binds to beta-2 receptors in bronchial smooth muscle, activating adenylyl cyclase and elevating cAMP — causing sustained airway relaxation for up to 12 hours per dose. It also stabilises mast cells, reducing release of bronchoconstricting mediators. Together, the two ingredients address both the inflammatory and bronchospastic components of chronic airway disease in a single coordinated inhaler.

How to Use the Quikhale SF HFA Inhaler

Priming — Essential First Step

Before using a new Quikhale SF inhaler — or after 7+ days of non-use — prime it by shaking well for 5 seconds and releasing 1 test spray into the air away from your face. This ensures the valve delivers an accurate dose.

Using Your Inhaler Correctly

Shake the inhaler firmly for 5 seconds before each use and remove the mouthpiece cap.
Breathe out fully away from the inhaler.
Seal your lips around the mouthpiece. Begin breathing in slowly, then press the canister once to release a puff simultaneously.
Continue inhaling slowly and deeply until your lungs are full, then hold breath for 10 seconds.
Wait 30 seconds, shake again, and repeat for the second puff if prescribed.
Rinse your mouth with water and spit — do not swallow. This prevents oral thrush.

If coordinating pressing and inhaling is difficult, ask your pharmacist about using a spacer device — it improves drug delivery and suits elderly or coordination-impaired patients. For eye health support during long-term inhaled corticosteroid use, explore our eye care products.

Quikhale SF 250 Dosage

Adults and Adolescents (12 Years and Over) — Asthma

One puff twice daily, morning and evening, approximately 12 hours apart. Always use the lowest effective dose and attend regular reviews. Do not self-adjust.

Adults — COPD

Two puffs twice daily as prescribed. If a dose is missed, take it as soon as possible unless the next scheduled dose is near — never double up. For women managing respiratory and other health conditions, explore our women's health collection, and for men our men's health range covers a full spectrum of treatment options.

Side Effects of Quikhale SF 250 HFA Inhaler

Most side effects are mild, manageable, and reduce with continued use and correct technique:

Upper respiratory tract infections — the most commonly reported effect
Headache and dizziness
Throat irritation, hoarseness, or voice changes
Oral thrush (candida) — prevented by rinsing after every use
Increased heart rate or palpitations
Nausea and vomiting
Nosebleeds (epistaxis)
Elevated blood glucose — particularly relevant for patients with diabetes
Shortness of breath immediately after inhalation (paradoxical bronchospasm — stop and use a rescue inhaler if this occurs)

Seek urgent attention if breathing worsens suddenly after use (paradoxical bronchospasm — stop and use a rescue inhaler), if a severe allergic reaction occurs (facial swelling, rash, breathing difficulty), or if you experience signs of adrenal suppression such as extreme fatigue or unexplained weight loss.

Drug Interactions and Who Should Not Use It

Key Drug Interactions

Always inform your doctor of all medications you take. Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole) significantly raise fluticasone blood levels, increasing the risk of adrenal suppression. Beta-blockers such as propranolol can counteract salmeterol's bronchodilator effect and trigger severe bronchospasm. Xanthine derivatives and loop diuretics taken alongside Quikhale SF may worsen hypokalaemia. For patients managing steroid-related eye risks such as glaucoma or cataracts, explore our eye drops range and eye care capsules for complementary ocular support.

Who Should Not Use Quikhale SF 250?

Patients allergic to salmeterol, fluticasone, or HFA-134a propellant.
Children under 12 years — not recommended without specialist supervision.
Patients experiencing acute asthma attacks — use a fast-acting rescue bronchodilator instead.
Patients with active pulmonary tuberculosis or serious untreated respiratory infections.

Order Quikhale SF 250 HFA Inhaler Online

Managing asthma and COPD long term requires reliable, consistent access to your maintenance inhaler. At Ed Care Store, we supply genuine Quikhale SF 250 HFA Inhalers with fast dispatch, discreet packaging, and competitive pricing. Visit our online shop to place your order, or contact our team for dosage guidance, interaction queries, or alternative inhaler recommendations. Medical Disclaimer This content is for informational purposes only and does not constitute medical advice. Quikhale SF 250 HFA is a prescription-only maintenance inhaler. Always consult a qualified doctor or respiratory specialist before starting, adjusting, or stopping any inhaler treatment. This product must not be used to treat acute asthma attacks — always keep a short-acting rescue inhaler accessible.